-+ 0.00%
-+ 0.00%
-+ 0.00%

HEXAGON BIO RAISES $62 MILLION SERIES C FINANCING TO ADVANCE HEX-360 INTO THE CLINIC AND EXPAND PIPELINE OF ANTIBODY-DRUG CONJUGATES WITH NOVEL PAYLOAD MECHANISMS

Reuters·10/23/2026 11:02:23